Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.
about
Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort.Importance of Drug Pharmacokinetics at the Site of ActionBrain structure, working memory and response inhibition in childhood leukemia survivors.Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.Neurocognitive, psychosocial, and quality-of-life outcomes in adult survivors of childhood non-Hodgkin lymphoma.The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia.Association between dehydroepiandrosterone-sulfate and attention in long-term survivors of childhood acute lymphoblastic leukemia treated with only chemotherapy.Neurodevelopmental consequences of pediatric cancer and its treatment: applying an early adversity framework to understanding cognitive, behavioral, and emotional outcomes.Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.Behavioral symptoms and psychiatric disorders in child and adolescent long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect?
P2860
Q30239868-288D9BB0-A6DE-46FE-A970-4491167224B9Q33648045-EC7064FE-3CC0-44F7-9243-5607ECA73372Q37653619-4FCBC0A5-0E25-40A1-BC61-DC6B46301428Q38813392-A6F28A83-1A5A-473B-8A42-F002B1A25869Q38848380-0BD33542-86F5-4BB7-B122-013F9FB1982CQ39361130-8022D11B-DAA1-4EF9-8031-6578A0969134Q40038719-E3DF47B0-E785-4AA0-A1AB-469B0F57BA6BQ40048832-049F7FB6-A92B-4BCB-BC68-41A3B3DEF9A9Q40223829-519ADD6A-289D-4039-8869-0289807B6830Q40446325-1D8E0518-2D2E-4D51-A467-F298C06BC8EBQ47561631-A5127D17-7752-4AD4-A89F-42EC2F8ACE41Q47655336-DAE79EDE-B62F-4D53-AEED-7979481D9E50Q53438232-78A29CEC-DA31-4841-B86D-4F5132C470F9Q53446289-FC1F51A5-2774-4B25-9E7A-73EF5D052EE0Q53769715-4B011F6A-FB60-4E1F-8C32-13D40892AA69
P2860
Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemotherapy Pharmacodynamics ...... Acute Lymphoblastic Leukemia.
@en
Chemotherapy Pharmacodynamics ...... Acute Lymphoblastic Leukemia.
@nl
type
label
Chemotherapy Pharmacodynamics ...... Acute Lymphoblastic Leukemia.
@en
Chemotherapy Pharmacodynamics ...... Acute Lymphoblastic Leukemia.
@nl
prefLabel
Chemotherapy Pharmacodynamics ...... Acute Lymphoblastic Leukemia.
@en
Chemotherapy Pharmacodynamics ...... Acute Lymphoblastic Leukemia.
@nl
P2093
P2860
P50
P921
P356
P1476
Chemotherapy Pharmacodynamics ...... Acute Lymphoblastic Leukemia.
@en
P2093
Cara Kimberg
Deokumar Srivastava
Kevin R Krull
Leslie L Robison
Melissa M Hudson
Robert Ogg
Slim Fellah
Tara M Brinkman
P2860
P304
P356
10.1200/JCO.2015.65.4574
P407
P577
2016-06-06T00:00:00Z